McKesson Corporation (MCK) Financial Statements (2026 and earlier)

Company Profile

Business Address 6555 STATE HIGHWAY 161
IRVING, TX 75039
State of Incorp. DE
Fiscal Year End March 31
Industry (SIC) 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

3/31/2026
12/31/2025
MRQ
3/31/2025
3/31/2024
3/31/2023
3/31/2022
3/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,9595,6914,8234,9153,8786,547
Cash and cash equivalent2,9595,6914,5834,6783,5326,278
Short-term investments   240237346269
Restricted cash and investments9426521403118
Receivables28,21325,64321,62219,41018,58319,181
Inventory, net of allowances, customer advances and progress billings27,06723,00121,13919,69118,70219,246
Inventory27,06723,00121,13919,69118,70219,246
Disposal group, including discontinued operation    174,51612
Other undisclosed current assets1,364798384258149278
Total current assets:59,69755,39847,97044,29246,23145,382
Noncurrent Assets
Operating lease, right-of-use asset2,0561,7821,7291,6351,5482,100
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization2,6342,5022,3162,1772,0922,581
Intangible asset, including goodwill, after accumulated amortization15,50311,48612,24212,22411,51012,371
Goodwill11,32410,02210,1329,9479,4519,493
Intangible asset, excluding goodwill, after accumulated amortization4,1791,4642,1102,2772,0592,878
Other noncurrent assets4,3003,9723,1861,9921,9172,581
Total noncurrent assets:24,49319,74219,47318,02817,06719,633
TOTAL ASSETS:84,19075,14067,44362,32063,29865,015
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities66,71360,15552,01246,68542,62942,962
Accounts payable60,68355,33047,09742,49038,08638,975
Accrued liabilities6,0304,8254,9154,1954,5433,987
Debt1,1321,19150968799742
Disposal group, including discontinued operation    54,7419
Other undisclosed current liabilities286258295299297390
Total current liabilities:68,13161,60452,35747,95748,46644,103
Noncurrent Liabilities
Long-term debt and lease obligation, including:5,4254,4635,5794,6265,0806,406
Finance lease, liability 163163173185206
Other undisclosed long-term debt and lease obligation5,4254,3005,4164,4533,5294,333
Liabilities, other than long-term debt10,73310,76711,10611,22710,17811,193
Deferred income tax liabilities1,1081,0299171,3871,4181,411
Estimated litigation liability5,1035,6016,1136,6257,2208,067
Other liabilities2,7412,6592,6101,8131,5401,715
Operating lease, liability1,7811,4781,4661,4021,3661,867
Other undisclosed noncurrent liabilities     1,3661,867
Total noncurrent liabilities:16,15815,23016,68515,85316,62419,466
Total liabilities:84,28976,83469,04263,81065,09063,569
Temporary equity, including noncontrolling interest802    1,271
Equity
Equity, attributable to parent(1,298)(2,074)(1,971)(1,857)(2,272)(21)
Common stock333322
Treasury stock, value(29,654)(27,439)(24,119)(20,997)(17,045)(13,670)
Additional paid in capital8,5468,3738,0487,7477,2756,925
Accumulated other comprehensive loss(903)(932)(881)(905)(1,534)(1,480)
Retained earnings20,71017,92114,97812,2959,0308,202
Equity, attributable to noncontrolling interest397380372367480196
Total equity:(901)(1,694)(1,599)(1,490)(1,792)175
TOTAL LIABILITIES AND EQUITY:84,19075,14067,44362,32063,29865,015

Income Statement (P&L) ($ in millions)

3/31/2026
12/31/2025
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Revenues433,590359,051308,951276,711263,966238,228
Cost of revenue
(Cost of Product and Service Sold)
(419,004)(345,728)(296,123)(264,353)(250,836)(226,080)
Gross profit:14,58613,32312,82812,35813,13012,148
Operating expenses(8,795)(8,901)(8,919)(7,977)(11,092)(17,188)
Operating income (loss):5,7914,4223,9094,3812,038(5,040)
Nonoperating income304202132497259223
Investment income, nonoperating 1731181071012
Other nonoperating income (expense) (38)3427910330
Interest and debt expense(279)(265)(252)(248)(369)(217)
Income (loss) from continuing operations before income taxes:5,8164,3593,7894,6301,928(5,034)
Income tax expense (benefit)(1,421)(878)(629)(905)(636)695
Income (loss) from continuing operations:4,3953,4813,1603,7251,292(4,339)
Income (loss) before gain (loss) on sale of properties:1,287(4,340)
Loss from discontinued operations    (3)(5)(1)
Net income (loss):4,3953,4813,1603,7221,287(4,340)
Net loss attributable to noncontrolling interest(231)(186)(158)(162)(173)(199)
Net income (loss) available to common stockholders, diluted:4,1643,2953,0023,5601,114(4,539)

Comprehensive Income ($ in millions)

3/31/2026
12/31/2025
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Net income (loss):4,3953,4813,1603,7221,287(4,340)
Net loss attributable to redeemable noncontrolling interest (12) 
Other comprehensive income (loss)(115)(51)24673115170
Comprehensive income (loss):4,2803,4303,1844,3951,402(4,170)
Comprehensive loss, net of tax, attributable to noncontrolling interest(231)(186)(158)(206)(172)(146)
Comprehensive income (loss), net of tax, attributable to parent:4,0493,2443,0264,1891,230(4,316)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: